Avalo Therapeutics, Inc. Share Price & Technical Analysis
AVTX · $13.74 (-1.58%)
Healthcare / Biotechnology
$13.74
-1.58%
Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Av…
Price chart
Seasonality
Jun has 3 positive and 2 negative years (last 5 years shown)
-14% return in Jun, -19% avg return in past 3 year Jun month.
-29% return in 2026, 46% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -17% | 9% | -12% | -12% | 18% | -14% | – | – | – | – | – | – | -29% |
| 25 | 12% | -11% | 10% | -40% | -20% | 22% | 58% | 21% | 37% | 41% | 6% | -2% | 131% |
| 24 | -47% | -6% | 395% | -14% | -32% | 10% | -6% | -39% | 34% | 38% | -27% | -22% | 284% |
| 23 | -22% | -36% | -31% | 57% | -3% | -87% | -44% | -52% | 23% | -11% | -33% | -39% | -277% |
| 22 | -42% | -27% | -6% | -44% | -14% | 38% | -44% | 26% | -30% | 76% | -9% | -8% | -84% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$755.10M
P/E ratio
—
52W high
$24.27
52W low
$4.06
Volume
25,15,343
Beta
0.79
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Avalo Therapeutics, Inc. share price today?
- Avalo Therapeutics, Inc. (AVTX) last traded around $13.74 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does AVTX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AVTX. Download the app for real-time alerts.
- How can I analyze Avalo Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.